Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients

Completed · Phase 2/Phase 3

Conditions studied: Hypogammaglobulinemia

In brief

This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.

Key facts

Study ID

NCT00137748

Run by

The Cleveland Clinic

People needed

50

Starts

2001-01-01

Expected to finish

2006-01-01

Last updated by the study team

2010-06-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Lung transplant
• Hypogammaglobulinemia

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.